Search
Cancel
Platform
Therapeutics
Therapeutics
Cell therapies
Pipeline
Partnerships
ioCells™
ioCells™
Discover ioCells
ioCells
ioWild Type Cells
ioDisease Model Cells
ioCRISPR-Ready Cells
Custom cell development
ioWild Type Cells
Glial cells
ioMicroglia
ioOligodendrocyte-like cells
Muscle cells
ioSkeletal Myocytes
Nerve cells
ioGABAergic Neurons
ioGlutamatergic Neurons
ioSensory Neurons
NEW! ioCRISPR-Ready Cells
CRISPR-Ready ioGlutamatergic Neurons
ioDisease Model Cells
Duchenne muscular dystrophy
ioSkeletal Myocytes DMD Exon 44 Deletion
ioSkeletal Myocytes DMD Exon 52 Deletion
FTD and ALS
ioGlutamatergic Neurons MAPT N279K/WT
ioGlutamatergic Neurons MAPT N279K/N279K
ioGlutamatergic Neurons MAPT P301S/WT
ioGlutamatergic Neurons MAPT P301S/P301S
ioGlutamatergic Neurons TDP-43 M337V/WT
ioGlutamatergic Neurons TDP-43 M337V/M337V
Huntington's disease
ioGlutamatergic Neurons HTT 50CAG/WT
Parkinson's and Gaucher disease
ioGlutamatergic Neurons GBA null/WT
ioGlutamatergic Neurons PRKN R275W/WT
ioGlutamatergic Neurons PRKN R275W/R275W
News and Events
News and Events
News
View all
Topics
Article
CEO views
New product
News
Podcast
Press release
Talk
Events
View all
Resources
Resources
Resources
View all
General resources
Application notes
bits of bio
Infographics
Posters
Publications
Talks
Videos
Video tutorials
Webinars
Product information
Brochures
User manuals
Protocol library
View all
Co-culture
ioGlutamatergic Neurons | ioMicroglia
ioGlutamatergic Neurons | ioGABAergic Neurons
Cell culture and preparation
ioMicroglia cell detachment
Cell characterisation and assays
ioGABAergic Neurons ICC
ioGlutamatergic Neurons ICC
ioMicroglia cytokine release
ioSkeletal Myocytes ICC
Blog
View all articles
Browse topics
CEO views
Culture
Expert opinion
Leadership
Science
Technology
Sustainability
About
About
Our company
About us
Leadership and Boards
Sustainability
Work with us
Partners
Careers
Careers
Working at bit.bio
Open roles
How we hire
Employee spotlights
Contact
Search
Rewriting the story
of human health —
one cell at a time
Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells
Cell identity coding platform
Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.
Explore our platform
Therapeutics
Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.
Learn more
ioCells™
Precision reprogrammed human iPSC-derived cells for research and drug discovery.
Discover ioCells
Latest news
Press Release
New collaboration to develop multi-cell models of the human brain
24.11.2023
Published by bit.bio
Read now
Press Release
bit.bio CEO wins in 2 categories at Great British Entrepreneur Awards
21.11.2023
Published by bit.bio
Read now
Article
bit.bio cell therapy pipeline featured in Endpoints News
17.11.2023
Published by Endpoints News
Read now
Podcast
Life Sciences: Invent podcast on cell and gene therapies
10.11.2023
Published by TTP Invent: Life Sciences - podcast
Read now